WHITING, ANDREW,AMBLER, CARRIE,COLES, MARK,CHISHOLM, DAVID
申请号：
CA3031889
公开号：
CA3031889A1
申请日:
2017.08.09
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
There are described novel compounds of formula I: (I) in which, in which A1, A2, A3, A4, R1 and R2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition； and methods related thereto.
